awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33590407-3AB6DAC5-33E5-4105-A124-B56012539CE5
Q33590407-3AB6DAC5-33E5-4105-A124-B56012539CE5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33590407-3AB6DAC5-33E5-4105-A124-B56012539CE5
Sorafenib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study.
P2860
Q33590407-3AB6DAC5-33E5-4105-A124-B56012539CE5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33590407-3AB6DAC5-33E5-4105-A124-B56012539CE5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b5b347caa1026dfe7d98b84df812de9bcb70cef3
P2860
Efficacy of sorafenib monotherapy versus sorafenib-based loco-regional treatments in advanced hepatocellular carcinoma.